AAA-604 (Novartis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAAA-604 (Novartis)
Drug Alias Nameintegrin beta-3/beta-5 antagonists (Novartis)
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionIntegrin beta-5 inhibitorsIntegrin beta-3 inhibitors
TargetsIntegrin beta-3Integrin beta-5
Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A